title: New once-a-day drugs: Truvada and Epzicom.
authors.affiliation: NorthStar Healthcare, Chicago, Illinois, USA. DSBergerMD@aol.com
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Berger
mesh_terms: D003841:Deoxycytidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D015224:Dideoxynucleosides; D004334:Drug Administration Schedule; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D009943:Organophosphorus Compounds / Q000008:administration & dosage*; D010349:Patient Compliance; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D003841:Deoxycytidine; D015224:Dideoxynucleosides; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D019259:Lamivudine; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; C492871:abacavir, lamivudine drug combination; D000099227:Abacavir